We favour such an explanation rather than a mechanistic difference between the respective oncogenes (Braf vs NRAS) per se, since in another similar inducible BrafV600E model repeated UVR exposures significantly accelerate MM when the oncogene is activated at 4 weeks of age (Goel et al., 2009). Here, NRAS is linked to Miyoshi myopathy.